Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 49, 2980-2987, June 1, 1989]
© 1989 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maio, M.
Right arrow Articles by Ferrone, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maio, M.
Right arrow Articles by Ferrone, S.

Modulation by Interferons of HLA Antigen, High-Molecular-Weight Melanoma-associated Antigen, and Intercellular Adhesion Molecule 1 Expression by Cultured Melanoma Cells with Different Metastatic Potential1

Michele Maio, Beena Gulwani, Jerome A. Langer, Robert S. Kerbel, Gregory J. Duigou, Paul B. Fisher and Soldano Ferrone2

Department of Microbiology and Immunology [M. M., B. G., S. F.], New York Medical College, Valhalla, New York 10595; Department of Molecular Genetics and Microbiology [J. A. L.], UMDNJ-Robert Wood Johnson Medical School, Piscataway, New Jersey 08854; Division of Cancer and Cell Biology [R. S. K.], Mount Sinai Hospital Research Institute, Toronto, Ontario M5G 1x5, Canada; Departments of Pathology and Urology [G. J. D., P. B. F.], Cancer Center/Institute of Cancer Research, Columbia University, College of Physicians and Surgeons, New York, New York 10032

The effect of leukocyte (IFN-{alpha}), fibroblast (IFN-ß), and immune (IFN-{gamma}) interferon and/or mezerein on the expression of HLA antigens and melanoma-associated antigens by the melanoma cell line MeWo and its metastatic variant MeM 50-10 was investigated, since this information may contribute to our understanding of the molecular mechanism(s) underlying the metastatic process and of the role of cell differentiation and growth suppression in the antigenic changes induced by interferon (IFN). The three types of IFN had no effect on the expression of high-molecular-weight melanoma-associated antigen, but enhanced that of HLA Class 1 antigens and of intercellular adhesion molecule 1 on MeWo and MeM 50-10 cells. The enhancing effect of IFN-{gamma} was more marked than that of IFN-{alpha} and IFN-ß. Furthermore IFN-{gamma} enhanced the expression of intercellular adhesion molecule 1 by MeM 50-10 cells more than by MeWo cells. IFN-ß was shown for the first time to induce HLA Class II antigens; the effect of IFN-ß, like that of IFN-{gamma}, is differential on the two cell lines and on the gene products of the HLA-D region. Like IFN-{gamma}, IFN-ß induced only HLA-DR antigens on MeM 50-10 cells. The results of Northern blot analysis with HLA-DRß, -DQß, and -DPß probes suggest that the differential modulation of the gene products of the HLA-D region by IFN-ß and IFN-{gamma} reflects transcriptional and posttranscriptional events. The differential susceptibility to modulation by IFN-ß and IFN-{gamma} of HLA Class II antigens on MeWo and MeM 50-10 cells is an intrinsic property of each cell line, since only small differences were detected in the number and/or affinity of receptors on the two cell lines.

Furthermore, the lack of marked effects of mezerein on the antigen-modulating activity of the three types of IFN, in spite of an enhancement of their differentiating activity, suggests that the changes in the antigenic profile induced by IFN do not represent a differentiation-related phenomenon.

1 This work was supported by NIH Grants AI21384, CA35675, CA37959, CA39559, and CA41233. P. B. F. is a Chernow Research Scholar.

2 To whom requests for reprints should be addressed, at Department of Microbiology and Immunology, New York Medical College, Valhalla, NY 10595.

Received 11/28/88. Revised 2/16/89. Accepted 2/28/89.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1989 by the American Association for Cancer Research.